1. Home
  2. SITC vs ANIK Comparison

SITC vs ANIK Comparison

Compare SITC & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SITE Centers Corp.

SITC

SITE Centers Corp.

HOLD

Current Price

$4.26

Market Cap

240.9M

Sector

Real Estate

ML Signal

HOLD

Logo Anika Therapeutics Inc.

ANIK

Anika Therapeutics Inc.

HOLD

Current Price

$16.03

Market Cap

200.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SITC
ANIK
Founded
1965
1983
Country
United States
United States
Employees
155
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
240.9M
200.9M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
SITC
ANIK
Price
$4.26
$16.03
Analyst Decision
Hold
Buy
Analyst Count
2
1
Target Price
$8.00
$17.00
AVG Volume (30 Days)
998.4K
63.8K
Earning Date
05-07-2026
04-29-2026
Dividend Yield
123.63%
N/A
EPS Growth
N/A
80.16
EPS
N/A
N/A
Revenue
N/A
$112,819,000.00
Revenue This Year
N/A
$5.98
Revenue Next Year
N/A
$7.42
P/E Ratio
$12.09
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.91
$7.90
52 Week High
$12.39
$16.24

Technical Indicators

Market Signals
Indicator
SITC
ANIK
Relative Strength Index (RSI) 36.23 66.00
Support Level N/A $13.88
Resistance Level $5.63 N/A
Average True Range (ATR) 0.19 0.53
MACD -0.02 0.14
Stochastic Oscillator 37.24 89.64

Price Performance

Historical Comparison
SITC
ANIK

About SITC SITE Centers Corp.

SITE Centers Corp is a self-administered and self-managed REIT that operates as a fully integrated real estate company. The company is engaged in the business of owning, leasing, acquiring, redeveloping, developing, and managing shopping centers.

About ANIK Anika Therapeutics Inc.

Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.

Share on Social Networks: